Key Events This Week
Sep 15: Stock plunges 13.01% to ₹20.00 amid broad market weakness
Sep 16: Marginal decline of 0.05% to ₹19.99 despite Sensex gains
Sep 17: Further dip of 0.50% to ₹19.89 as technical indicators weaken
Sep 18: Slight recovery of 1.66% to ₹20.22 following downgrade announcement
Monday, 15 September 2026: Sharp Decline Amid Market Sell-Off
Trading resumed after the weekend with Vivid Global Industries Ltd’s stock price dropping sharply by 13.01% to close at ₹20.00. This decline was more pronounced than the Sensex’s 1.69% fall to 35,169.62, reflecting heightened selling pressure on the stock. The volume of 26,197 shares indicated active trading, possibly driven by concerns over the company’s valuation and sector outlook. The steep drop set a bearish tone for the week.
Tuesday, 16 September 2026: Stabilisation Despite Market Gains
The stock price remained almost flat, slipping marginally by 0.05% to ₹19.99, even as the Sensex gained 0.30% to 35,276.25. The reduced volume of 10,199 shares suggested cautious investor participation. This relative stability contrasted with the previous day’s sharp fall, indicating some consolidation. However, the lack of upward momentum hinted at lingering uncertainty about the company’s near-term prospects.
Wednesday, 17 September 2026: Continued Pressure Ahead of Downgrade
Vivid Global’s shares declined further by 0.50% to ₹19.89, while the Sensex advanced 0.46% to 35,439.31. The low volume of 6,233 shares reflected subdued trading interest. This day coincided with the downgrade announcement by MarketsMOJO, which lowered the company’s rating from Hold to Sell, citing a shift in valuation grading from very expensive to expensive and mixed financial and technical signals. The downgrade underscored concerns about the company’s modest profitability, weak long-term growth, and inconsistent technical indicators.
This week's disclosed pick, a Large Cap from NBFC, comes with precise Target Price and analysis. Check if you're positioned right for this opportunity!
- - Precise target price set
- - Weekly selection live
- - Position check opportunity
Thursday, 18 September 2026: Slight Recovery Post Downgrade
Following the downgrade, the stock rebounded by 1.66% to close at ₹20.22, outperforming the Sensex’s 0.52% gain to 35,625.23. The volume remained modest at 6,104 shares. This uptick may reflect bargain hunting or short-term technical buying after the prior days’ declines. Nonetheless, the overall weekly trend remained negative, with the stock down 12.05% from the previous Friday’s close of ₹22.99.
Weekly Price Performance Comparison
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-09-15 | Rs.20.00 | -13.01% | 35,169.62 | -1.69% |
| 2026-09-16 | Rs.19.99 | -0.05% | 35,276.25 | +0.30% |
| 2026-09-17 | Rs.19.89 | -0.50% | 35,439.31 | +0.46% |
| 2026-09-18 | Rs.20.22 | +1.66% | 35,625.23 | +0.52% |
Valuation and Financial Analysis
MarketsMOJO’s downgrade to Sell was driven primarily by a reassessment of Vivid Global’s valuation and financial metrics. The company’s price-to-earnings ratio stands at 23.12, down from previously very expensive levels but still indicating a premium relative to the broader commodity chemicals sector. Its price-to-book value of 1.10 suggests the stock trades slightly above net asset value, typical for micro-cap firms but a cautionary sign for value investors.
Enterprise value multiples such as EV to EBIT at 8.79 and EV to EBITDA at 6.59 further reflect an expensive valuation stance, although these are more moderate compared to peers like Titan Biotech (PE 49.57) and Oriental Aromatics (PE 326.38). The PEG ratio of 0.32 indicates earnings growth is favourable relative to price, supported by a 32% profit rise over the past year. However, the company’s modest return on equity of 4.75% and return on capital employed of 11.68% do not strongly justify a premium rating.
Financial trends are mixed. While quarterly net sales reached ₹15.16 crores and profit after tax was ₹0.59 crores for the nine months ended, signalling short-term improvement, the long-term operating profit has declined at a CAGR of -0.84% over five years. The average EBIT to interest coverage ratio of 0.60 highlights vulnerability to debt servicing costs, and the average ROE of 3.56% over recent years points to limited profitability relative to equity.
Why settle for Vivid Global Industries Ltd? SwitchER evaluates this micro-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
Technical and Quality Assessment
The technical outlook for Vivid Global is mixed and contributed to the cautious stance. The technical grade shifted from bullish to mildly bullish, reflecting weakening momentum. Weekly MACD remains bullish but monthly MACD is only mildly so. The Relative Strength Index (RSI) shows no clear directional signal, indicating indecision among traders. Bollinger Bands readings are bearish on the weekly chart but mildly bullish monthly, while moving averages on the daily chart are mildly bullish. The KST indicator is bearish weekly but bullish monthly, and Dow Theory assessments are mildly bullish on both weekly and monthly timeframes.
Quality metrics highlight structural weaknesses typical of micro-cap stocks, including lower liquidity and less stable ownership. The company’s modest ROE and ROCE figures suggest limited efficiency in generating shareholder returns. Despite recent consistent quarterly profitability, the weak long-term fundamentals and low operating profit growth raise concerns about earnings sustainability.
Comparative Sector Context and Long-Term Performance
Within the commodity chemicals sector, Vivid Global’s valuation is expensive but not the highest. Peers such as J.G. Chemicals trade at a fair valuation with a PE of 30.57 and EV to EBITDA of 22.40, while Titan Biotech is very expensive with a PE of 49.57. Vivid Global’s EV to EBITDA of 6.59 is comparatively attractive, and its PEG ratio of 0.32 suggests potential undervaluation relative to growth prospects.
However, the stock’s long-term returns have been disappointing. Five-year and ten-year returns stand at -33.03% and -28.96% respectively, significantly underperforming the Sensex’s gains of 25.92% and 159.85% over the same periods. This underperformance underscores persistent structural challenges despite recent short-term improvements.
Key Takeaways
- Significant weekly price decline: The stock fell 12.05% versus a 0.41% drop in the Sensex, reflecting company-specific concerns.
- Downgrade to Sell: Driven by a shift in valuation grading and mixed financial and technical signals.
- Valuation remains expensive: PE of 23.12 and EV/EBITDA of 6.59 indicate premium pricing despite some moderation.
- Mixed financial trends: Short-term profit growth contrasts with weak long-term operating profit decline and low ROE.
- Technical indicators inconsistent: Mildly bullish to bearish signals suggest market indecision.
- Micro-cap risks: Lower liquidity and ownership concentration add to volatility concerns.
- Long-term underperformance: Negative returns over five and ten years highlight structural challenges.
Conclusion
The week for Vivid Global Industries Ltd was marked by a notable share price decline and a downgrade to a Sell rating, reflecting a comprehensive reassessment of valuation, financial health, and technical outlook. While the company has demonstrated some short-term operational improvements and a relatively attractive PEG ratio, its expensive valuation, weak long-term profitability, and mixed technical signals warrant caution. The stock’s significant underperformance relative to the Sensex over longer horizons further emphasises the challenges faced by this micro-cap commodity chemicals firm. Investors should carefully consider these factors in the context of sector volatility and company-specific risks.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
